Out-of-pocket costs can rise dramatically for children with chronic health issues if a family changes marketplace coverage, according to a new study.
Exchange enrollees and insurers fret over a lawsuit that could end federal help with copays and deductibles.
Los subsidios que ayudan a las personas con sus copagos y deducibles, distintos a los créditos impositivos para pagar las primas, están en medio de una batalla legal luego de una demanda republicana.
A growing number of patients fail to fill prescriptions because the cost of cancer drugs is too high.
Nearly half of the people in this month’s Kaiser Family Foundation tracking poll believe the Republican legislation will increase the number of uninsured Americans and increase coverage costs.
Before the health law, buying an individual policy that included coverage for pregnancy and labor was extremely difficult.
Epinephrine, the active ingredient in EpiPens, expires after 18 months, and the auto-injector device can’t be refilled or reused. Health professionals are looking for work-arounds they say could save the health system millions.
Intense, “high touch” care that focuses on housing as well as health care brings down medical costs for the most expensive patients. But it’s been hard to replicate successful programs.
Si piensas que porque tienes seguro de salud a través de tu trabajo en una gran compañía, no te afectará si los republicanos cambian el Obamacare, piénsalo dos veces. Muchas de las provisiones de la ley también aplican a los planes ofrecidos por grandes empleadores.
With the future of Obamacare on the line, workers might want to consider what benefits they have gained through the landmark law.
En 2017, muchos más planes de salud en los mercados de seguros requerirán que los consumidores paguen una sustancial parte del costo de los medicamentos más caros, dicen, para disuadir a pacientes muy enfermos de elegir sus planes.
A Kaiser Health News analysis finds that the portion of federal marketplace plans requiring people to pay a third or more of the cost of specialty drugs have jumped from 37 to 63 percent since 2014.
The bronze plans’ lower premiums — coupled with the health law’s out-of-pocket-spending protections — may make these policies an attractive option.
Majorities of Democrats, Republicans and independents support making sure high-cost drugs for chronic conditions are affordable.
The problem, known as balance billing, happens when patients are treated by an out-of-network professional at an in-network facility. Gov. Jerry Brown is expected to sign the legislation.
Cost pressures may induce patients to forego needed care, some worry.
Four years after a huge push to speed generics to market, the FDA has more than 4,000 generics waiting for approval.
The standardized policy options would provide a way for consumers to make apples-to-apples comparisons.
A study explores how coverage gains resulting from the federal health law may have changed people’s health care habits and spending.
News reports have led many consumers to blame drugmakers for the rapidly rising costs of some commonly used generic drugs. But changes made by insurers often play a major role, too.